“If we look at major trends, people are living longer, on average, so there’s a rise in chronic diseases associated with aging. Meanwhile, healthcare workers are in short supply, and physicians and nurses do not have enough time for patients. Yet everyone has powerful computers in their pockets that give them access to technology, education, and information. Put all that together, and it’s the perfect moment for digital solutions to come to the market, change behavior, and enhance health outcomes at scale” - Bozidar Jovicevic, Global head of Digital Therapeutics, Sanofi

Pharma – Physician Interactions in the Digital Era

Indian Pharma companies will have to create hybrid employees, who can be designated as the Digital Task Force (DTF). Just as STFs were created to create a better perception and improve engagement with specialist doctors, DTF can rebuild relationships with doctors on a new premise of helping them to gain digital advantage to better manage their practice and patients.

IMS Health Market Reflection Report for August 2016

The Indian Pharmaceutical Market (IPM) was valued at Rs. 10,426 crores in the month of August 2016 clocking a strong 18% growth over same period last year (SPLY). This was the second consecutive month where the IPM crossed the 10,000 crore mark.

Contact Us
Terms of Service
Privacy Statement

Facebook

Twitter

Youtube

Healthcare Trends

A Tale of Two Companies – Sun Pharma’s Odyssey and Organon’s Second Act

Sun Pharma’s Odyssey and Organon’s Second Act – And...

The Semaglutide Gold Rush: Miracle Cure or Market Mirage?

The Indian Pharmaceutical Market (IPM) has entered a definitive...

The Strait of Hormuz—Why Geopolitics Is Now Core to India’s Healthcare Strategy

"Those who cannot remember the past are condemned to...

Brecht Vanneste has been appointed as Managing Director of MSD India

He steps into the role with a clear mandate...

From Collapse to Catalyst: Orchid Pharma’s Innovation-Led Phoenix Rise and the AMR Challenge

Opening Frame: The "Silent" Pandemic Meets Strategic Grit In the...

Marketing

A Tale of Two Companies – Sun Pharma’s Odyssey and Organon’s Second Act

Sun Pharma’s Odyssey and Organon’s Second Act – And...

The Semaglutide Gold Rush: Miracle Cure or Market Mirage?

The Indian Pharmaceutical Market (IPM) has entered a definitive...

The Strait of Hormuz—Why Geopolitics Is Now Core to India’s Healthcare Strategy

"Those who cannot remember the past are condemned to...

Brecht Vanneste has been appointed as Managing Director of MSD India

He steps into the role with a clear mandate...

From Collapse to Catalyst: Orchid Pharma’s Innovation-Led Phoenix Rise and the AMR Challenge

Opening Frame: The "Silent" Pandemic Meets Strategic Grit In the...

Policies/Sales

A Tale of Two Companies – Sun Pharma’s Odyssey and Organon’s Second Act

Sun Pharma’s Odyssey and Organon’s Second Act – And...

The Semaglutide Gold Rush: Miracle Cure or Market Mirage?

The Indian Pharmaceutical Market (IPM) has entered a definitive...

The Strait of Hormuz—Why Geopolitics Is Now Core to India’s Healthcare Strategy

"Those who cannot remember the past are condemned to...

Brecht Vanneste has been appointed as Managing Director of MSD India

He steps into the role with a clear mandate...

From Collapse to Catalyst: Orchid Pharma’s Innovation-Led Phoenix Rise and the AMR Challenge

Opening Frame: The "Silent" Pandemic Meets Strategic Grit In the...

Strategy

A Tale of Two Companies – Sun Pharma’s Odyssey and Organon’s Second Act

Sun Pharma’s Odyssey and Organon’s Second Act – And...

The Semaglutide Gold Rush: Miracle Cure or Market Mirage?

The Indian Pharmaceutical Market (IPM) has entered a definitive...

The Strait of Hormuz—Why Geopolitics Is Now Core to India’s Healthcare Strategy

"Those who cannot remember the past are condemned to...

Brecht Vanneste has been appointed as Managing Director of MSD India

He steps into the role with a clear mandate...

From Collapse to Catalyst: Orchid Pharma’s Innovation-Led Phoenix Rise and the AMR Challenge

Opening Frame: The "Silent" Pandemic Meets Strategic Grit In the...

Thought Leadership
Healthcare C-Suite Movements
Digital in Pharma
Events
- FFE+CEO RT
- BrandStorm
Solutions & Pricing
Partner

Hot topics

Digital as Emergent Strategy – Lessons for Pharma from Honda

The door to the magical realm is open! Are...

Without Re-skilling, You’re as Good as Un-Schooled

Pharma companies that used large field forces for multiple divisions, selling the same me-too products to create a resounding Share-of-the-Voice in the market are beginning to Stare-at-the-Diminishing-Returns for investments on traditional sales and marketing strategies, if they can be called strategies at all in the first place. Most pharma companies and professionals like Black & Yellow cabs, continue to hope against hope, that somehow they will be able to continue to hold on to their businesses and jobs till their shares are sold and EMIs are paid. After that, who cares? The answer to pharma and healthcare’s challenges will need a combination of profound domain knowledge and experience combined with digital skills to engage Rx customers meaningfully.

How Smart Medical Reps Can Beat Bots

Today's Brand Equity cover — a woman lost in...

Dr. Tarun Gupta Tribute Issue

Editor's Note - This issue of MedicinMan is dedicated to the memory of Dr. Tarun Gupta, TG as he was fondly called. Executive Editor, Salil Kallianpur, dear friend Subrato Banerjee and long-time MedicinMan patron Vivek Hattangadi, pen their tributes to TG.